ERCC1 expression in peripheral blood lymphocytes and non-small cell lung cancer

郝萍; 赵伟鹏; 刁鑫伟; 王卫东; 关华军; 胡义德; 陈正堂

您当前的位置：

首页 >

文章列表页 >

ERCC1 expression in peripheral blood lymphocytes and non-small cell lung cancer

更新时间：2026-01-09

- ERCC1 expression in peripheral blood lymphocytes and non-small cell lung cancer
- Journal of Army Medical University Vol. 31, Issue 12, Pages: 1201-1204(2009)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R331.144;R730.43;R734.2
- Published：2009
- 稿件说明：
移动端阅览
郝萍,赵伟鹏,刁鑫伟,王卫东,关华军,胡义德,陈正堂.人非小细胞肺癌与外周血淋巴细胞表达ERCC1的相关性研究[J].陆军军医大学学报(原第三军医大学学报),2009,31(12):1201-1204.

　HAO Ping,ZHAO Wei-peng,DIAO Xin-wei,WANG Wei-dong,GUAN Huai-jun,HU Yi-de,CHENG Zheng-tang.ERCC1 expression in peripheral blood lymphocytes and non-small cell lung cancer[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(12):1201-1204.
郝萍,赵伟鹏,刁鑫伟,王卫东,关华军,胡义德,陈正堂.人非小细胞肺癌与外周血淋巴细胞表达ERCC1的相关性研究[J].陆军军医大学学报(原第三军医大学学报),2009,31(12):1201-1204. DOI：

　HAO Ping,ZHAO Wei-peng,DIAO Xin-wei,WANG Wei-dong,GUAN Huai-jun,HU Yi-de,CHENG Zheng-tang.ERCC1 expression in peripheral blood lymphocytes and non-small cell lung cancer[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(12):1201-1204. DOI：

摘要

目的探讨切除修复交叉互补基因1(excision repair cross-complementation group 1

ERCC1)在人非小细胞肺癌（non-small cell lung cancer NSCLC）癌组织和外周血淋巴细胞(peripheral blood lymphocyte

PBL)中的表达及其相关性，以期建立临床实用简便的肿瘤学指标。方法采用间接二步法免疫荧光化学染色检测47例Ⅱ期、Ⅲ期NSCLC患者癌组织和PBL中ERCC1的表达及健康人PBL中ERCC1的表达。结果 ERCC1在癌组织、NSCLC患者PBL和健康人PBL中的表达分别为53.19%（25/47）、48.94%（23/47）和20%（4/20），其中癌组织的ERCC1表达与NSCLC患者PBL的表达呈正相关，20例健康人PBL的ERCC1表达阳性率显著低于NSCLC患者。ERCC1的表达与临床病理类型无关。结论检测NSCLC患者PBL的ERCC1表达可间接反应癌组织的ERCC1表达状况。

Abstract

Objective To explore the correlation of the expression of excision repair cross-complementation group 1 (ERCC1) with non-small cell lung cancer (NSCLC) tissues and peripheral blood lymphocytes (PBLs). Methods ERCC1 expressions in specimens and PBLs from 47 patients with Stage II and III NSCLC and healthy PBLs were detected with double immunofluorescence staining. Results The positive expression rates of ERCC1 were 53.19%

48.94%

and 20% in carcinoma tissues

PBLs of NSCLC

and PBLs of healthy people

respectively. The expression rate of ERCC1 in carcinoma tissues was higher than that in PBLs of healthy people (P0.05) and positively correlated with that in PBLs of the patients. Conclusion The expression of ERCC1 in PBLs of NSCLC patients can indirectly represent ERCC1 expression in carcinoma tissues.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Integrative model combining deep learning, clinical and radiomic features enhances EGFR mutation prediction in non-small cell lung cancer

Preparation of doxorubicin-loaded polyphyllin H liposomes and synergistic anti-tumor activity against non-small cell lung cancer in vitro

Development of a postoperative recurrence prediction model for stage Ⅰ non-small cell lung cancer patients using multimodal data based on machine learning

Effect of chronic obstructive pulmonary disease on immunotherapy in patients with advanced non-small cell lung cancer

Efficacy and resistance of EGFR-TKIs for first-line treatment for compound EGFR mutations positive non-small cell lung cancer

Related Author

YANG Taotao

CHEN Wei

CHEN Cancan

YAN Wanying

WANG Dawei

XIONG Kunlin

SUN Zhiyuan

WANG Xianqi

Related Institution

Department of Radiology，First Affiliated Hospital， Army Medical University （Third Military Medical University）

Infervision Medical Technology Co.， Ltd

Department of Radiology， Daping Hospital， Army Medical University

Department of Diagnostic Radiology， Eastern Theatre General Hospital

Department of Medical Service,No. Hospital of Joint Logistics Support Force

⁰